| 前收市價 | 4.4400 |
| 開市 | 4.5600 |
| 買盤 | 4.4600 x 200 |
| 賣出價 | 4.5100 x 200 |
| 今日波幅 | 4.4800 - 4.7000 |
| 52 週波幅 | 1.0800 - 5.0000 |
| 成交量 | |
| 平均成交量 | 1,180,024 |
| 市值 | 234.849M |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.9300 |
| 業績公佈日 | 2024年7月31日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 8.50 |
Insider MonkeyG1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
ZacksG1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
G1 Therapeutics (GTHX) delivered earnings and revenue surprises of -5.26% and 4.84%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Insider Monkey
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1 Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.27. G1 Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
